News Sanofi/Regeneron eczema data paves way for year's biggest la... Companies look to take on Pfizer after series of setbacks.
News After missing out on CEO job, Novo's US head quits The pressure on Novo Nordisk's diabetes portfolio is mounting in the US - and the situation seems even more precarious after its top exec in the region quit.
News Sanofi cholesterol drug can stay on US market - for now Sales of Praluent can continue during patent case appeal.
News New general manager and diabetes medical leader for Sanofi U... Hugo Fry and Dr Hubert Bland take on new roles at Sanofi UK
News Sanofi's Kevzara gains first approval in Canada Sanofi and Regeneron's new rheumatoid arthritis (RA) drug Kevzara has gained its first global approval in Canada.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
